Elucidating the role of N440K mutation in SARS-CoV-2 spike – ACE-2 binding affinity and COVID-19 severity by virtual screening, molecular docking and dynamics approach

References

• Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015). GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1–2, 19–25. https://doi.org/10.1016/j.softx.2015.06.001
   Google Scholar
• Ambrose, J. M., Veeraraghavan, V. P., Kullappan, M., Chellapandiyan, P., Surapaneni, K. M., & Manivel, V. A. (2021). Comparison of immunological profiles of SARS-CoV-2 Variants in the COVID-19 pandemic trends: An immunoinformatics approach. Antibiotics, 10(5), 535. https://doi.org/10.3390/antibiotics10050535
   Google Scholar
• Antony, P., & Vijayan, R. (2021). Role of SARS-CoV-2 and ACE2 variations in COVID-19. Biomedical Journal, 44(3), 235–244. https://doi.org/10.1016/j.bj.2021.04.006
   PubMed Web of Science ®Google Scholar
• Augusto, G., Mohsen, M. O., Zinkhan, S., Liu, X., Vogel, M., & Bachmann, M. F. (2021). In vitro data suggest that Indian delta variant B.1.617 of SARS-CoV-2 escapes neutralization by both receptor affinity and immune evasion. Allergy, https://doi.org/10.1111/all.15065
   Google Scholar
• Barnes, C. O., Jette, C. A., Abernathy, M. E., Dam, K.-M A., Esswein, S. R., Gristick, H. B., Malyutin, A. G., Sharaf, N. G., Huey-Tubman, K. E., Lee, Y. E., Robbiani, D. F., Nussenzweig, M. C., West, A. P., & Bjorkman, P. J. (2020). SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature, 588(7839), 682–687. https://doi.org/10.1038/s41586-020-2852-1
   PubMed Web of Science ®Google Scholar
• Benet, L. Z., Hosey, C. M., Ursu, O., & Oprea, T. I. (2016). BDDCS, the Rule of 5 and drugability. Advanced Drug Delivery Reviews, 101, 89–98. https://doi.org/10.1016/j.addr.2016.05.007
   PubMed Web of Science ®Google Scholar
• Bulka, B., desJardins, M., & Freeland, S. J. (2006). An interactive visualization tool to explore the biophysical properties of amino acids and their contribution to substitution matrices. BMC Bioinformatics, 7, 329. https://doi.org/10.1186/1471-2105-7-329
   PubMed Web of Science ®Google Scholar
• Burley, S. K., Berman, H. M., Kleywegt, G. J., Markley, J. L., Nakamura, H., & Velankar, S. (2017). Protein Data Bank (PDB): The single global macromolecular structure archive. Methods in Molecular Biology, 1607, 627–641. https://doi.org/10.1007/978-1-4939-7000-1_26
   PubMedGoogle Scholar
• Chen, J., Xia, L., Liu, L., Xu, Q., Ling, Y., Huang, D., Huang, W., Song, S., Xu, S., Shen, Y., & Lu, H. (2020). Antiviral activity and safety of darunavir/cobicistat for the treatment of COVID-19. Open Forum Infectious Diseases, 7(7), ofaa241. https://doi.org/10.1093/ofid/ofaa241
   PubMed Web of Science ®Google Scholar
• Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, 42717. https://doi.org/10.1038/srep42717
   PubMed Web of Science ®Google Scholar
• de Vries, S. J., van Dijk, A. D., Krzeminski, M., van Dijk, M., Thureau, A., Hsu, V., Wassenaar, T., & Bonvin, A. M. (2007). HADDOCK versus HADDOCK: New features and performance of HADDOCK2.0 on the CAPRI targets. Proteins, 69(4), 726–733. https://doi.org/10.1002/prot.21723
   PubMed Web of Science ®Google Scholar
• Dominguez, C., Boelens, R., & Bonvin, AMJJ. (2003). HADDOCK: A protein-protein docking approach based on biochemical or biophysical information. Journal of the American Chemical Society, 125(7), 1731–1737. https://doi.org/10.1021/ja026939x
   PubMed Web of Science ®Google Scholar
• Frediansyah, A., Nainu, F., Dhama, K., Mudatsir, M., & Harapan, H. (2021). Remdesivir and its antiviral activity against COVID-19: A systematic review. Clinical Epidemiology and Global Health, 9, 123–127. https://doi.org/10.1016/j.cegh.2020.07.011
   PubMed Web of Science ®Google Scholar
• Gomez, C. E., Perdiguero, B., & Esteban, M. (2021). Emerging SARS-CoV-2 variants and impact in global vaccination programs against SARS-CoV-2/COVID-19. Vaccines, 9(3), 243. https://doi.org/10.3390/vaccines9030243
   PubMed Web of Science ®Google Scholar
• Hanwell, M. D., Curtis, D. E., Lonie, D. C., Vandermeersch, T., Zurek, E., & Hutchison, G. R. (2012). Avogadro: An advanced semantic chemical editor, visualization, and analysis platform. Journal of Cheminformatics, 4(1), 17. https://doi.org/10.1186/1758-2946-4-17
   PubMed Web of Science ®Google Scholar
• Hsu, K. C., Chen, Y. F., Lin, S. R., & Yang, J. M. (2011). iGEMDOCK: A graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis. BMC Bioinformatics, 12 Suppl 1, S33. https://doi.org/10.1186/1471-2105-12-S1-S33
   PubMed Web of Science ®Google Scholar
• Indari, O., Jakhmola, S., Manivannan, E., & Jha, H. C. (2021). An update on antiviral therapy against SARS-CoV-2: How far have we come? Frontiers in Pharmacology, 12, 632677. https://doi.org/10.3389/fphar.2021.632677
   PubMed Web of Science ®Google Scholar
• Irwin, J. J., & Shoichet, B. K. (2005). ZINC–a free database of commercially available compounds for virtual screening. Journal of Chemical Information and Modeling, 45(1), 177–182. https://doi.org/10.1021/ci049714+
   PubMed Web of Science ®Google Scholar
• Jafary, F., Jafari, S., & Ganjalikhany, M. R. (2021). In silico investigation of critical binding pattern in SARS-CoV-2 spike protein with angiotensin-converting enzyme 2. Scientific Reports, 11(1), 6927 https://doi.org/10.1038/s41598-021-86380-2
   PubMed Web of Science ®Google Scholar
• Jin, Y., Yang, H., Ji, W., Wu, W., Chen, S., Zhang, W., & Duan, G. (2020). Virology, epidemiology, pathogenesis, and control of COVID-19. Viruses, 12(4), 372. https://doi.org/10.3390/v12040372
   PubMed Web of Science ®Google Scholar
• Johnson, B. A., Xie, X., Bailey, A. L., Kalveram, B., Lokugamage, K. G., Muruato, A., Zou, J., Zhang, X., Juelich, T., Smith, J. K., Zhang, L., Bopp, N., Schindewolf, C., Vu, M., Vanderheiden, A., Winkler, E. S., Swetnam, D., Plante, J. A., Aguilar, P., … Menachery, V. D. (2021). Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis. Nature, 591(7849), 293–299. https://doi.org/10.1038/s41586-021-03237-4
   PubMed Web of Science ®Google Scholar
• Kaplan, W., & Littlejohn, T. G. (2001). Swiss-PDB viewer (deep view). Briefings in Bioinformatics, 2(2), 195–197. https://doi.org/10.1093/bib/2.2.195
   PubMedGoogle Scholar
• Kim, S., Thiessen, P. A., Bolton, E. E., Chen, J., Fu, G., Gindulyte, A., Han, L., He, J., He, S., Shoemaker, B. A., Wang, J., Yu, B., Zhang, J., & Bryant, S. H. (2016). PubChem substance and compound databases. Nucleic Acids Research, 44(D1), D1202–D1213. https://doi.org/10.1093/nar/gkv951
   PubMed Web of Science ®Google Scholar
• Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Hengartner, N., Giorgi, E. E., Bhattacharya, T., Foley, B., Hastie, K. M., Parker, M. D., Partridge, D. G., Evans, C. M., Freeman, T. M., de Silva, T. I., McDanal, C., Perez, L. G., Tang, H., … Montefiori, D. C, Sheffield COVID-19 Genomics Group. (2020). Tracking changes in SARS-CoV-2 spike: Evidence that D614G increases infectivity of the COVID-19 virus. Cell, 182(4), 812–827.e19. https://doi.org/10.1016/j.cell.2020.06.043
   PubMed Web of Science ®Google Scholar
• Lan, J., Ge, J., Yu, J., Shan, S., Zhou, H., Fan, S., Zhang, Q., Shi, X., Wang, Q., Zhang, L., & Wang, X. (2020). Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature, 581(7807), 215–220. https://doi.org/10.1038/s41586-020-2180-5
   PubMed Web of Science ®Google Scholar
• Li, W., Greenough, T. C., Moore, M. J., Vasilieva, N., Somasundaran, M., Sullivan, J. L., Farzan, M., & Choe, H. (2004). Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2. Journal of Virology, 78(20), 11429–11433. https://doi.org/10.1128/JVI.78.20.11429-11433.2004
   PubMed Web of Science ®Google Scholar
• Li, W., Zhang, C., Sui, J., Kuhn, J. H., Moore, M. J., Luo, S., Wong, S.-K., Huang, I.-C., Xu, K., Vasilieva, N., Murakami, A., He, Y., Marasco, W. A., Guan, Y., Choe, H., & Farzan, M. (2005). Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. The EMBO Journal, 24(8), 1634–1643. https://doi.org/10.1038/sj.emboj.7600640
   PubMed Web of Science ®Google Scholar
• Lo, H. S., Hui, K. P. Y., Lai, H. M., He, X., Khan, K. S., Kaur, S., Huang, J., Li, Z., Chan, A. K. N., Cheung, H. H., Ng, K. C., Ho, J. C. W., Chen, Y. W., Ma, B., Cheung, P. M., Shin, D., Wang, K., Lee, M. H., Selisko, B., Eydoux, C., Guillemot, J. C., … Ng, W. L. (2021). Simeprevir potently suppresses SARS-CoV-2 replication and synergizes with remdesivir. ACS Central Science, 7(5), 792–802. https://doi.org/10.1021/acscentsci.0c01186
   PubMed Web of Science ®Google Scholar
• Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., Bi, Y., Ma, X., Zhan, F., Wang, L., Hu, T., Zhou, H., Hu, Z., Zhou, W., Zhao, L., … Tan, W. (2020). Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet (London, England), 395(10224), 565–574. https://doi.org/10.1016/S0140-6736(20)30251-8
   PubMed Web of Science ®Google Scholar
• MacKerell, A. D. Jr (2001). Atomistic models and force fields. In O. M. Becker, A. D. MacKerell Jr, B. Roux, & M. Watanabe (Eds.), Computational biochemistry and biophysics (pp. 7–38). Marcel Dekker Inc.: New York.
   Google Scholar
• Mehrbod, P., Ande, S. R., Alizadeh, J., Rahimizadeh, S., Shariati, A., Malek, H., Hashemi, M., Glover, K. K. M., Sher, A. A., Coombs, K. M., & Ghavami, S. (2019). The roles of apoptosis, autophagy and unfolded protein response in arbovirus, influenza virus, and HIV infections. Virulence, 10(1), 376–413. https://doi.org/10.1080/21505594.2019.1605803
   PubMed Web of Science ®Google Scholar
• Mei, M., & Tan, X. (2021). Current strategies of antiviral drug discovery for COVID-19. Frontiers in Molecular Biosciences, 8, 671263. https://doi.org/10.3389/fmolb.2021.671263
   PubMed Web of Science ®Google Scholar
• Milani, M., Donalisio, M., Bonotto, R. M., Schneider, E., Arduino, I., Boni, F., Lembo, D., Marcello, A., & Mastrangelo, E. (2021). Combined in silico and in vitro approaches identified the antipsychotic drug lurasidone and the antiviral drug elbasvir as SARS-CoV2 and HCoV-OC43 inhibitors. Antiviral Research, 189, 105055. https://doi.org/10.1016/j.antiviral.2021.105055
   PubMed Web of Science ®Google Scholar
• Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791. https://doi.org/10.1002/jcc.21256
   PubMed Web of Science ®Google Scholar
• Rani, P. R., Imran, M., Lakshmi, J. V., Jolly, B., Jain, A., Surekha, A., Senthivel, V., Chandrasekhar, P., Divakar, M. K., Srinivasulu, D., Bhoyar, R. C., Vanaja, P. R., Scaria, V., & Sivasubbu, S. (2021). Symptomatic reinfection of SARS-CoV-2 with spike protein variant N440K associated with immune escape. Journal of Medical Virology, 93(7), 4163–4165. https://doi.org/10.1002/jmv.26997
   PubMed Web of Science ®Google Scholar
• Ratajczak, M. Z., & Kucia, M. (2020). SARS-CoV-2 infection and overactivation of Nlrp3 inflammasome as a trigger of cytokine "storm" and risk factor for damage of hematopoietic stem cells. Leukemia, 34(7), 1726–1729. https://doi.org/10.1038/s41375-020-0887-9
   PubMed Web of Science ®Google Scholar
• Salamanna, F., Maglio, M., Landini, M. P., & Fini, M. (2020). Body localization of ACE-2: On the trail of the keyhole of SARS-CoV-2. Frontiers in Medicine, 7, 594495. https://doi.org/10.3389/fmed.2020.594495
   PubMed Web of Science ®Google Scholar
• Schrors, B., Riesgo-Ferreiro, P., Sorn, P., Gudimella, R., Bukur, T., Rosler, T., Lower, M., & Sahin, U. (2021). Large-scale analysis of SARS-CoV-2 spike-glycoprotein mutants demonstrates the need for continuous screening of virus isolates. PLoS One, 16(9), e0249254. https://doi.org/10.1371/journal.pone.0249254
   PubMed Web of Science ®Google Scholar
• Seeliger, D., & de Groot, B. L. (2010). Ligand docking and binding site analysis with PyMOL and Autodock/Vina. Journal of Computer-Aided Molecular Design, 24(5), 417–422. https://doi.org/10.1007/s10822-010-9352-6
   PubMed Web of Science ®Google Scholar
• Shamsi, A., Mohammad, T., Anwar, S., AlAjmi, M. F., Hussain, A., Rehman, M. T., Islam, A., & Hassan, M. I. (2020). Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: possible implication in COVID-19 therapy. Bioscience Reports, 40, BSR20201256. https://doi.org/10.1042/BSR20201256
   PubMed Web of Science ®Google Scholar
• Shen, K., Yang, Y., Wang, T., Zhao, D., Jiang, Y., Jin, R., Zheng, Y., Xu, B., Xie, Z., Lin, L., Shang, Y., Lu, X., Shu, S., Bai, Y., Deng, J., Lu, M., Ye, L., Wang, X., Wang, Y., & Gao, L., Global Pediatric Pulmonology Alliance. (2020). Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: Experts' consensus statement. World Journal of Pediatrics: WJP, 16(3), 223–231. https://doi.org/10.1007/s12519-020-00343-7
   PubMed Web of Science ®Google Scholar
• Shu, Y., & McCauley, J. (2017). GISAID: Global initiative on sharing all influenza data. From vision to reality. Eurosurveillance, 22, 30494. https://doi.org/10.2807/1560-7917.ES.2017.22.13.30494
   Web of Science ®Google Scholar
• Singh, T. U., Parida, S., Lingaraju, M. C., Kesavan, M., Kumar, D., & Singh, R. K. (2020). Drug repurposing approach to fight COVID-19. Pharmacological Reports: PR, 72(6), 1479–1508. https://doi.org/10.1007/s43440-020-00155-6
   PubMed Web of Science ®Google Scholar
• Tandel, D., Gupta, D., Sah, V., & Harshan, K. H. (2021). N440K variant of SARS-CoV-2 has higher infectious fitness. bioRxiv. https://doi.org/10.1101/2021.04.30.441434
   Google Scholar
• Thomson, E. C., Rosen, L. E., Shepherd, J. G., Spreafico, R., da Silva Filipe, A., Wojcechowskyj, J. A., Davis, C., Piccoli, L., Pascall, D. J., Dillen, J., Lytras, S., Czudnochowski, N., Shah, R., Meury, M., Jesudason, N., De Marco, A., Li, K., Bassi, J., O'Toole, A., … Snell, G., COVID-19 Genomics UK (COG-UK) Consortium. (2021). Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity. Cell, 184(5), 1171–1187.e20. https://doi.org/10.1016/j.cell.2021.01.037
   PubMed Web of Science ®Google Scholar
• van Dorp, L., Richard, D., Tan, C. C. S., Shaw, L. P., Acman, M., & Balloux, F. (2020). No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2. Nature Communications, 11(1), 5986. https://doi.org/10.1038/s41467-020-19818-2
   PubMed Web of Science ®Google Scholar
• van Zundert, G. C. P., Rodrigues, J. P. G. L. M., Trellet, M., Schmitz, C., Kastritis, P. L., Karaca, E., Melquiond, A. S. J., van Dijk, M., de Vries, S. J., & Bonvin, A. M. J. J. (2016). The HADDOCK2.2 web server: User-friendly integrative modeling of biomolecular complexes. Journal of Molecular Biology, 428(4), 720–725. https://doi.org/10.1016/j.jmb.2015.09.014
   PubMed Web of Science ®Google Scholar
• Vanommeslaeghe, K., Hatcher, E., Acharya, C., Kundu, S., Zhong, S., Shim, J., Darian, E., Guvench, O., Lopes, P., Vorobyov, I., & Mackerell, A. D. (2010). CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. Journal of Computational Chemistry, 31(4), 671–690. https://doi.org/10.1002/jcc.21367
   PubMed Web of Science ®Google Scholar
• Walensky, R. P., Walke, H. T., & Fauci, A. S. (2021). SARS-CoV-2 variants of concern in the United States-challenges and opportunities. JAMA, 325(11), 1037–1038. https://doi.org/10.1001/jama.2021.2294
   PubMed Web of Science ®Google Scholar
• Wallace, A. C., Laskowski, R. A., & Thornton, J. M. (1995). LIGPLOT: A program to generate schematic diagrams of protein-ligand interactions. Protein Engineering, 8(2), 127–134. https://doi.org/10.1093/protein/8.2.127
   PubMedGoogle Scholar
• Wan, Y., Shang, J., Graham, R., Baric, R. S., & Li, F. (2020). Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS. Journal of Virology, 94(7), e00127. https://doi.org/10.1128/JVI.00127-20
   PubMed Web of Science ®Google Scholar
• Weisblum, Y., Schmidt, F., Zhang, F., DaSilva, J., Poston, D., Lorenzi, J. C. C., Muecksch, F., Rutkowska, M., Hoffmann, H.-H., Michailidis, E., Gaebler, C., Agudelo, M., Cho, A., Wang, Z., Gazumyan, A., Cipolla, M., Luchsinger, L., Hillyer, C. D., Caskey, M., … Bieniasz, P. D. (2020). Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. eLife, 9, e61312. https://doi.org/10.7554/eLife.61312
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2020). Coronavirus disease (COVID-2019) situation reports. Retrieved March 20, 2021, from https://wwwwhoint/emergencies/diseases/novel-coronavirus-2019/situation-reports.
   Google Scholar
• Xia, H., Cao, Z., Xie, X., Zhang, X., Chen, J. Y.-C., Wang, H., Menachery, V. D., Rajsbaum, R., & Shi, P.-Y. (2020). Evasion of type I interferon by SARS-CoV-2. Cell Reports, 33(1), 108234. https://doi.org/10.1016/j.celrep.2020.108234
   PubMed Web of Science ®Google Scholar
• Xue, X., Shi, J., Xu, H., Qin, Y., Yang, Z., Feng, S., Liu, D., Jian, L., Hua, L., Wang, Y., Zhang, Q., Huang, X., Zhang, X., Li, X., Chen, C., Guo, J., Tang, W., & Liu, J. (2021). Dynamics of binding ability prediction between spike protein and human ACE2 reveals the adaptive strategy of SARS-CoV-2 in humans. Scientific Reports, 11(1), 3187. https://doi.org/10.1038/s41598-021-82938-2
   PubMed Web of Science ®Google Scholar
• Zhang, L., Jackson, C. B., Mou, H., Ojha, A., Peng, H., Quinlan, B. D., Rangarajan, E. S., Pan, A., Vanderheiden, A., Suthar, M. S., Li, W., Izard, T., Rader, C., Farzan, M., & Choe, H. (2020). SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity. Nature Communications, 11(1), 6013. https://doi.org/10.1038/s41467-020-19808-4
   PubMed Web of Science ®Google Scholar
• Zhou, D., Dejnirattisai, W., Supasa, P., Liu, C., Mentzer, A. J., Ginn, H. M., Zhao, Y., Duyvesteyn, H. M. E., Tuekprakhon, A., Nutalai, R., Wang, B., Paesen, G. C., Lopez-Camacho, C., Slon-Campos, J., Hallis, B., Coombes, N., Bewley, K., Charlton, S., Walter, T. S., … Screaton, G. R. (2021). Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera. Cell, 184(9), 2348–2361. https://doi.org/10.1016/j.cell.2021.02.037
   PubMed Web of Science ®Google Scholar